Will High Court Provide Clarity On 'Clear Evidence'?
The U.S. Supreme Court may soon revisit one of its seminal decisions defining products liability law for pharmaceutical manufacturers. That decision — Wyeth v. Levine — addressed whether a branded manufacturer...To view the full article, register now.
Already a subscriber? Click here to view full article